John M. Leonard, President and CEO

NTLA 467,352 shares
Q 8,252 shares

The estimated Net Worth of John M. Leonard is at least $13,430,212.00. John M. Leonard owns over 467,352 units of Intellia Therapeutics, Inc. stock worth over $12,151,152.00.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
4th November 2020NTLA - Intellia Therapeutics, Inc.50,000Open or private sale467,352$26.00$1,300,000.00$12,151,152.00
4th November 2020NTLA - Intellia Therapeutics, Inc.50,000Exercise of derivative517,352$6.83$341,500.00$3,533,514.16
7th October 2020NTLA - Intellia Therapeutics, Inc.5,000Open or private sale467,352$21.83$109,150.00$10,202,294.16
7th October 2020NTLA - Intellia Therapeutics, Inc.5,000Exercise of derivative472,352$6.83$34,150.00$3,226,164.16
16th May 2019Q - Quintiles IMS Holdings, Inc.1,478Grant/award etc.8,252$0.00
20th December 2019Q - Quintiles IMS Holdings, Inc.10,100Open or private sale8,252$155.00$1,565,500.00$1,279,060.00
20th December 2019Q - Quintiles IMS Holdings, Inc.10,100Open or private sale18,352$151.00$1,525,100.00$2,771,152.00
20th December 2019Q - Quintiles IMS Holdings, Inc.7,000Exercise of derivative28,452$64.52$451,640.00$1,835,723.04
20th December 2019Q - Quintiles IMS Holdings, Inc.6,600Exercise of derivative21,452$64.86$428,076.00$1,391,376.72
20th December 2019Q - Quintiles IMS Holdings, Inc.6,600Exercise of derivative14,852$64.93$428,538.00$964,340.36
6th May 2020Q - Quintiles IMS Holdings, Inc.1,492Grant/award etc.9,744$0.00
3rd June 2020NTLA - Intellia Therapeutics, Inc.5,000Open or private sale467,352$21.83$109,150.00$10,202,294.16
3rd June 2020NTLA - Intellia Therapeutics, Inc.5,000Exercise of derivative472,352$6.83$34,150.00$3,226,164.16
1st July 2020NTLA - Intellia Therapeutics, Inc.5,000Open or private sale467,352$21.83$109,150.00$10,202,294.16
1st July 2020NTLA - Intellia Therapeutics, Inc.5,000Exercise of derivative472,352$6.83$34,150.00$3,226,164.16
6th August 2020NTLA - Intellia Therapeutics, Inc.5,000Open or private sale467,352$21.83$109,150.00$10,202,294.16
6th August 2020NTLA - Intellia Therapeutics, Inc.5,000Exercise of derivative472,352$6.83$34,150.00$3,226,164.16
1st September 2020NTLA - Intellia Therapeutics, Inc.5,000Open or private sale467,352$21.83$109,150.00$10,202,294.16
1st September 2020NTLA - Intellia Therapeutics, Inc.5,000Exercise of derivative472,352$6.83$34,150.00$3,226,164.16